Masipram 5 Tablet contains Escitalopram Oxalate 5 mg, a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram works by increasing the levels of serotonin, a neurotransmitter, in the brain, which helps improve mood, reduce anxiety, and enhance overall emotional balance. Masipram 5 is indicated for adults and adolescents over 12 years of age and is typically initiated at a dose of 5 mg once daily, with adjustments made based on clinical response and tolerability. The medication is generally well-tolerated, but patients may experience side effects such as nausea, headache, insomnia, dry mouth, or dizziness, especially during the initial treatment phase. It is important to adhere to prescribed dosages and consult a healthcare professional before discontinuing therapy to avoid withdrawal symptoms. Masipram 5 should be used cautiously in patients with a history of bipolar disorder, seizures, or serotonin syndrome. Regular monitoring by a healthcare provider is recommended to assess therapeutic efficacy and detect any adverse reactions. This medication should not be combined with monoamine oxidase inhibitors (MAOIs) or other serotonergic agents without medical supervision.